出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年3月
空カプセル市場 : タイプ（ゼラチン、非ゼラチン）、機能性（即時放出、持続放出、遅延放出）、治療用途、エンドユーザー（医薬品、栄養補助食品、化粧品、参照研究所）、地域別 – 2028年までの世界予測
Empty Capsules Market by Type (Gelatin, Non-gelatin), Functionality (Immediate-Release, Sustained-Release, Delayed Release), Therapeutic Application, End User (Pharmaceutical, Nutraceutical, Cosmetic, Reference Laboratories) & Region – Global Forecasts to 2028
| ページ数 | 240 |
| 図表数 | 285 |
| 種別 | 英文調査報告書 |
| 価格 |
The global empty capsules market size is projected to reach USD 4.9 billion by 2028 from USD 3.2 billion in 2023, at a CAGR of 9.3% during the forecast period. Factors such as increasing use of nutraceuticals and benefits associated with empty capsules, are driving the market growth at a faster pace.
“The non-gelatin capsules segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
On the basis of type, the empty capsules market is segmented into gelatin capsules, and non-gelatin capsules. The non-gelatin capsules segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of vegetarian products. This is likely to have a positive impact on segmental growth.
“The immediate-release capsules segment is expected to hold a dominant share in 2023.”
Based on the functionality, the market is segmented into immediate-release capsules, sustained-release capsules, and delayed-release capsules. The immediate release capsules segment is expected to grow at a faster pace during the forecast period due to its advantages such as higher bioavailability, easy digestion, and low cost.
“In 2022, the antibiotic & antibacterial drugs segment held a dominant share.”
Based on therapeutic application, the empty capsules market is segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other therapeutic applications. The antibiotic & antibacterial drugs segment held a dominant share of the empty capsules market. Development of new antibiotics in capsule dosage form to project the market growth.
“The nutraceutical industry segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
Based on end user, the empty capsules market is segmented into pharmaceutical industry, nutraceutical industry, cosmetic industry, and reference laboratories. The nutraceutical industry segment to grow at the highest CAGR during the forecast period. The growing use of dietary supplements is one of the major factors anticipated to project market growth.
“Asia Pacific region is likely to grow at faster pace.”
The empty capsules market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of empty capsules market. The dominance of the region is attributable to various factors such as the presence of dominant and key market players in the region coupled with increasing use of dietary supplements. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the low cost of manufacturing, rising scientific research in the region, and the emergence of new market players in the empty capsules market.
The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 90%, and Demand Side – 10%
• By Designation (Supply Side): Managers – 35%, CXOs & Directors – 20%, Executives- 45%
• By Region: North America -20%, Europe -25%, Asia-Pacific -40%, Latin America -10%, and Middle East and Africa -5%
Lists of Companies Profiled in the Report:
• Capsugel (US)
• ACG Worldwide (India)
• Mitsubishi Chemical Holding Corporation (US)
• CapsCanada Corporation (Canada)
• Natural Capsules (India)
• Suheung Co., Ltd. (South Korea)
• Nectar Lifesciences Ltd. (India)
• Qingdao Yiqing Medicinal Capsule (China)
• Shanxi Guangsheng Medicinal Capsule (China)
• Health Caps India (India)
• Medi-Caps (India)
• Snail Pharma Industry (China)
• Roxlor (US)
• Sunil Healthcare (India)
• BioCaps Enterprise (US)
• Bright Pharma Caps (US)
• Comed Chemicals (India)
• Saviour Caps (India)
• Fortcaps Healthcare (India)
• Shaoxing Zhongya Capsule (China)
• Erawat Pharma (India)
• Farmacapsulas (Colombia)
• Zhejiang Yuexi Capsule (Taiwan)
• LFA Machines Oxfords (US)
• Shaoxing Kangke (China)
• Shree Pharma Caps (India)
Research Coverage:
This report provides a detailed picture of the empty capsules market. It aims at estimating the size and future growth potential of the market across different segments, such as type, functionality, therapeutic application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall empty capsules market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
目次
1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS AND EXCLUSIONS 34
1.3 MARKET SCOPE 34
FIGURE 1 EMPTY CAPSULES MARKET SEGMENTATION 34
1.3.1 YEARS CONSIDERED 35
1.4 CURRENCY CONSIDERED 35
1.5 LIMITATIONS 35
1.6 STAKEHOLDERS 36
1.7 SUMMARY OF CHANGES 36
1.7.1 RECESSION IMPACT 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH APPROACH 37
FIGURE 2 RESEARCH DESIGN 37
2.1.1 SECONDARY RESEARCH 38
2.1.2 PRIMARY RESEARCH 38
FIGURE 3 EMPTY CAPSULES MARKET: PRIMARY RESPONDENTS 39
2.2 MARKET ESTIMATION METHODOLOGY 39
FIGURE 4 EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VALUE (2022) 39
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 40
FIGURE 6 MARKET VOLUME ESTIMATION, 2022 40
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 41
FIGURE 7 INSIGHTS ON EMPTY CAPSULES MARKET FROM PRIMARY EXPERTS 41
2.3 MARKET GROWTH RATE PROJECTIONS 42
FIGURE 8 EMPTY CAPSULES MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 43
2.4 DATA TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.5 RESEARCH ASSUMPTIONS 45
2.6 RISK ANALYSIS 45
3 EXECUTIVE SUMMARY 46
FIGURE 10 EMPTY CAPSULES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 46
FIGURE 11 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION) 47
FIGURE 12 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023 VS. 2028 (USD MILLION) 47
FIGURE 13 EMPTY CAPSULES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 48
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF EMPTY CAPSULES MARKET 49
4 PREMIUM INSIGHTS 50
4.1 EMPTY CAPSULES MARKET OVERVIEW 50
FIGURE 15 INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE GROWTH 50
4.2 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE AND COUNTRY (2022) 50
FIGURE 16 GELATIN CAPSULES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 50
4.3 EMPTY CAPSULES MARKET SHARE, BY APPLICATION, 2023 VS. 2028 51
FIGURE 17 ANTIBIOTIC AND ANTIBACTERIAL DRUGS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 51
4.4 EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 51
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 19 EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
TABLE 1 EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 53
5.2.1.1 Increasing demand for nutraceuticals 53
5.2.1.2 Growth in pharmaceutical market and increasing number of clinical trials and R&D activities 54
5.2.1.3 Advancements in capsule delivery technologies 54
5.2.1.4 Benefits of capsules over other dosage forms 55
5.2.2 RESTRAINTS 55
5.2.2.1 Cultural practices and dietary restrictions 55
5.2.3 OPPORTUNITIES 55
5.2.3.1 Expansion of capsule production in emerging countries 55
5.2.3.2 Development of halal gelatin and vegetarian capsules 56
5.2.4 CHALLENGES 57
5.2.4.1 Rising prices and lower availability of raw materials in gelatin industry 57
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 58
FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS 58
5.4 PRICING ANALYSIS 58
TABLE 2 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION (2022) 58
5.5 TECHNOLOGY ANALYSIS 59
5.5.1 ENTERIC CAPSULE TECHNOLOGIES 59
5.5.2 PROTEIN DELIVERY CAPSULE TECHNOLOGIES 59
5.6 VALUE CHAIN ANALYSIS 60
FIGURE 21 EMPTY CAPSULES MARKET: VALUE CHAIN ANALYSIS 60
5.7 ECOSYSTEM ANALYSIS 61
FIGURE 22 ECOSYSTEM ANALYSIS: EMPTY CAPSULES MARKET 61
TABLE 3 ROLE IN ECOSYSTEM 62
5.8 PORTER’S FIVE FORCES ANALYSIS 62
TABLE 4 EMPTY CAPSULES MARKET: PORTER’S FIVE FORCES ANALYSIS 62
5.8.1 THREAT OF NEW ENTRANTS 62
5.8.2 THREAT OF SUBSTITUTES 63
5.8.3 BARGAINING POWER OF SUPPLIERS 63
5.8.4 BARGAINING POWER OF BUYERS 63
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 63
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA 63
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EMPTY CAPSULES 63
FIGURE 24 KEY BUYING CRITERIA FOR EMPTY CAPSULES 64
5.10 PATENT ANALYSIS 65
FIGURE 25 PATENT APPLICATIONS RELATED TO EMPTY CAPSULES, JANUARY 2012–MARCH 2023 65
TABLE 5 LIST OF FEW PATENTS IN EMPTY CAPSULES MARKET 66
5.11 TRADE ANALYSIS 67
TABLE 6 EXPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES) 67
TABLE 7 IMPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES) 67
5.12 REGULATORY ANALYSIS 68
5.13 PHARMACEUTICAL GELATIN MARKET 70
5.14 INDUSTRY TRENDS 70
5.14.1 RISING DEMAND FOR EMPTY CAPSULES IN NUTRACEUTICAL AND COSMETICS INDUSTRIES 70
5.14.2 GROWING DEMAND AND ADOPTION OF VEGETARIAN/NON-GELATIN CAPSULES 71
6 EMPTY CAPSULES MARKET, BY TYPE 72
6.1 INTRODUCTION 73
TABLE 8 EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 73
TABLE 9 EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (BILLION UNITS) 73
6.2 GELATIN CAPSULES 74
TABLE 10 GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 74
TABLE 11 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 75
TABLE 12 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS) 75
TABLE 13 NORTH AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 14 EUROPE: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 15 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
6.2.1 PORCINE GELATIN 76
6.2.1.1 Porcine gelatin segment to dominate market 76
TABLE 16 PORCINE GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 77
TABLE 17 NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 18 EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 19 ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78
6.2.2 BOVINE-DERIVED GELATIN 78
6.2.2.1 Bovine-derived gelatin widely accepted in halal pharmaceuticals market 78
TABLE 20 BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 79
TABLE 21 NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 22 EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 23 ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80
6.2.3 BONE MEAL 80
6.2.3.1 Bone meal gelatin gained importance in recent years 80
TABLE 24 BONE MEAL GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 25 NORTH AMERICA: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 26 EUROPE: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 27 ASIA PACIFIC: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
6.2.4 OTHER GELATIN SOURCES 82
TABLE 28 OTHER GELATIN SOURCE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 29 NORTH AMERICA: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 30 EUROPE: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 31 ASIA PACIFIC: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
6.3 NON-GELATIN CAPSULES 84
TABLE 32 NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 85
TABLE 33 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 34 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS) 86
TABLE 35 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 36 EUROPE: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 37 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
6.3.1 HYDROXYPROPYL METHYLCELLULOSE 87
6.3.1.1 HPMC dominates non-gelatin capsules market 87
TABLE 38 HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 39 NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 40 EUROPE: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 41 ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
6.3.2 PULLULAN AND STARCH 89
6.3.2.1 High manufacturing costs offset advantageous aspects of pullulan and starch 89
TABLE 42 PULLULAN AND STARCH CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 43 NORTH AMERICA: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 44 EUROPE: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 45 ASIA PACIFIC: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
7 EMPTY CAPSULES MARKET, BY FUNCTIONALITY 92
7.1 INTRODUCTION 93
TABLE 46 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 93
7.2 IMMEDIATE-RELEASE CAPSULES 93
7.2.1 INCREASING APPLICATIONS OF IMMEDIATE-RELEASE CAPSULES TO PROPEL MARKET 93
TABLE 47 IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 48 NORTH AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 49 EUROPE: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 50 ASIA PACIFIC: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
7.3 SUSTAINED-RELEASE CAPSULES 95
7.3.1 RISING USE OF SUSTAINED-RELEASE FORMULATIONS IN TREATING CHRONIC DISEASES TO DRIVE MARKET 95
TABLE 51 SUSTAINED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 96
TABLE 52 NORTH AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 53 EUROPE: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 54 ASIA PACIFIC: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
7.4 DELAYED-RELEASE CAPSULES 97
7.4.1 GROWING PREFERENCE FOR TARGETED DRUG DELIVERY TO FUEL MARKET GROWTH 97
TABLE 55 DELAYED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 98
TABLE 56 NORTH AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 57 EUROPE: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 58 ASIA PACIFIC: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
8 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION 100
8.1 INTRODUCTION 101
TABLE 59 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 101
8.2 ANTIBIOTIC AND ANTIBACTERIAL DRUGS 101
8.2.1 EMERGENCE OF NOVEL ANTIBIOTICS IN CAPSULE FORM AND INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET 101
TABLE 60 EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 61 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 62 EUROPE: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 63 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 103
8.3 DIETARY SUPPLEMENTS 103
8.3.1 RISING DEMAND FOR DIETARY SUPPLEMENTS TO SUPPORT GROWTH 103
TABLE 64 EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 65 NORTH AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 66 EUROPE: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 67 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 105
8.4 ANTACID AND ANTIFLATULENT PREPARATIONS 105
8.4.1 INCREASING DEMAND FOR GASTROINTESTINAL FORMULATIONS TO DRIVE MARKET 105
TABLE 68 EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 69 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 70 EUROPE: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 71 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 107
8.5 ANTIANEMIC PREPARATIONS 107
8.5.1 RISING INCIDENCE OF ANEMIA WORLDWIDE TO DRIVE GROWTH 107
TABLE 72 EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 73 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 74 EUROPE: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 75 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 109
8.6 ANTI-INFLAMMATORY DRUGS 109
8.6.1 RISING EMPHASIS ON GENERICS TO FAVOR MARKET GROWTH 109
TABLE 76 EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 77 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 78 EUROPE: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 79 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 111
8.7 CARDIOVASCULAR THERAPY DRUGS 111
8.7.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO CONTRIBUTE TO MARKET GROWTH 111
TABLE 80 EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 81 NORTH AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 82 EUROPE: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 83 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 113
8.8 COUGH AND COLD DRUGS 113
8.8.1 GROWING ADOPTION OF OTC FORMULATIONS AND SELF-MEDICATION PRACTICES TO DRIVE GROWTH 113
TABLE 84 EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 85 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 86 EUROPE: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 87 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION) 115
8.9 OTHER THERAPEUTIC APPLICATIONS 115
TABLE 88 EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 89 NORTH AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 90 EUROPE: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 91 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 117
9 EMPTY CAPSULES MARKET, BY END USER 118
9.1 INTRODUCTION 119
TABLE 92 EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 119
9.2 PHARMACEUTICAL INDUSTRY 119
9.2.1 INCREASING EMPHASIS ON DRUG DEVELOPMENT TO DRIVE GROWTH 119
TABLE 93 EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 94 NORTH AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 95 EUROPE: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 96 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 121
9.3 NUTRACEUTICAL INDUSTRY 121
9.3.1 INCREASING DEMAND FOR DIETARY SUPPLEMENTS IN DEVELOPED AND DEVELOPING COUNTRIES TO SUPPORT GROWTH 121
TABLE 97 EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 98 NORTH AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 99 EUROPE: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 100 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 123
9.4 COSMETICS INDUSTRY 123
9.4.1 GELATIN-BASED CAPSULES ARE IDEAL FOR DELIVERING COSMETIC PRODUCTS 123
TABLE 101 EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 102 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 103 EUROPE: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 104 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 125
9.5 RESEARCH LABORATORIES 125
9.5.1 RISING CLINICAL TRIAL ACTIVITY TO DRIVE MARKET GROWTH 125
TABLE 105 EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 106 NORTH AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 107 EUROPE: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 108 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 127
10 EMPTY CAPSULES MARKET, BY REGION 128
10.1 INTRODUCTION 129
TABLE 109 EMPTY CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 110 EMPTY CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS) 129
10.2 NORTH AMERICA 130
FIGURE 26 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT 131
TABLE 111 NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 112 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 113 NORTH AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 114 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 115 NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 133
TABLE 116 NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 133
TABLE 117 NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 134
10.2.1 US 134
10.2.1.1 US to dominate North American market during forecast period 134
TABLE 118 US: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 119 US: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 120 US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 121 US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 136
TABLE 122 US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 136
TABLE 123 US: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 137
10.2.2 CANADA 137
10.2.2.1 Rising government focus on utilization of generics as means for controlling healthcare expenditure to drive growth 137
TABLE 124 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 125 CANADA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 126 CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 127 CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 139
TABLE 128 CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 129 CANADA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 140
10.2.3 NORTH AMERICA: RECESSION IMPACT 140
10.3 EUROPE 140
TABLE 130 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 131 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 132 EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 133 EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 134 EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 142
TABLE 135 EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 136 EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 143
10.3.1 GERMANY 143
10.3.1.1 Presence of large number of pharmaceutical and nutraceutical manufacturers propelling demand for empty capsules 143
TABLE 137 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 138 GERMANY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 139 GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 140 GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 145
TABLE 141 GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 145
TABLE 142 GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 146
10.3.2 UK 146
10.3.2.1 Rising adoption of generics to drive market growth 146
TABLE 143 UK: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 144 UK: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 145 UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 146 UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 147
TABLE 147 UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 148 UK: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 148
10.3.3 FRANCE 148
10.3.3.1 High demand for pharmaceutical products to drive market growth 148
TABLE 149 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 150 FRANCE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 151 FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 152 FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 150
TABLE 153 FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 154 FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 151
10.3.4 ITALY 151
10.3.4.1 Growing presence of small and medium-sized CMOs likely to drive market 151
TABLE 155 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 156 ITALY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 157 ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 158 ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 153
TABLE 159 ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 153
TABLE 160 ITALY: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 154
10.3.5 SPAIN 154
10.3.5.1 Consolidation of biotechnology sector and availability of government support to drive growth 154
TABLE 161 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 162 SPAIN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 163 SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 164 SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 155
TABLE 165 SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 156
TABLE 166 SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 156
10.3.6 REST OF EUROPE 156
TABLE 167 REST OF EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 168 REST OF EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 169 REST OF EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 170 REST OF EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 158
TABLE 171 REST OF EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 159
TABLE 172 REST OF EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 159
10.3.7 EUROPE: RECESSION IMPACT 159
10.4 ASIA PACIFIC 160
FIGURE 27 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT 161
TABLE 173 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 174 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 175 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 176 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 177 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 163
TABLE 178 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 163
TABLE 179 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 164
10.4.1 CHINA 164
10.4.1.1 Low manufacturing costs on account of availability of raw materials to accelerate growth 164
TABLE 180 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 181 CHINA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 182 CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 183 CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 166
TABLE 184 CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 166
TABLE 185 CHINA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 167
10.4.2 JAPAN 167
10.4.2.1 Japan to be largest market for empty capsules in Asia Pacific 167
TABLE 186 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 187 JAPAN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 188 JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 189 JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 169
TABLE 190 JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 169
TABLE 191 JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 170
10.4.3 INDIA 170
10.4.3.1 Increased exports of empty capsules to drive market growth 170
TABLE 192 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 193 INDIA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 194 INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 195 INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 172
TABLE 196 INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 172
TABLE 197 INDIA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 173
10.4.4 REST OF ASIA PACIFIC 173
TABLE 198 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 199 REST OF ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 200 REST OF ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 201 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 174
TABLE 202 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 175
TABLE 203 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 175
10.4.5 ASIA PACIFIC: RECESSION IMPACT 175
10.5 LATIN AMERICA 176
10.5.1 STRATEGIC EXPANSIONS BY LEADING MARKET PLAYERS TO DRIVE GROWTH 176
TABLE 204 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 205 LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 206 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 207 LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 177
TABLE 208 LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 178
TABLE 209 LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 178
10.5.2 LATIN AMERICA: RECESSION IMPACT 178
10.6 MIDDLE EAST & AFRICA 179
10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET 179
TABLE 210 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 211 MIDDLE EAST & AFRICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 212 MIDDLE EAST & AFRICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 213 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 180
TABLE 214 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION) 181
TABLE 215 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION) 181
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 182
11 COMPETITIVE LANDSCAPE 183
11.1 INTRODUCTION 183
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 183
FIGURE 28 EMPTY CAPSULES MARKET: STRATEGIES ADOPTED 184
11.3 MARKET SHARE ANALYSIS 185
FIGURE 29 EMPTY CAPSULES MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2022) 185
TABLE 216 EMPTY CAPSULES MARKET: DEGREE OF COMPETITION 185
11.4 REVENUE ANALYSIS 187
FIGURE 30 REVENUE ANALYSIS FOR KEY COMPANIES (2020–2022) 187
11.5 COMPANY EVALUATION MATRIX 187
11.5.1 STARS 187
11.5.2 EMERGING LEADERS 187
11.5.3 PERVASIVE PLAYERS 187
11.5.4 PARTICIPANTS 188
FIGURE 31 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX, 2022 188
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 189
11.6.1 PROGRESSIVE COMPANIES 189
11.6.2 STARTING BLOCKS 189
11.6.3 RESPONSIVE COMPANIES 189
11.6.4 DYNAMIC COMPANIES 189
FIGURE 32 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 190
11.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 191
11.7.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES) 191
TABLE 217 OVERALL FOOTPRINT ANALYSIS OF KEY PLAYERS 191
11.7.2 INDUSTRY FOOTPRINT OF COMPANIES (25 COMPANIES) 192
TABLE 218 INDUSTRY FOOTPRINT ANALYSIS OF KEY PLAYERS 192
11.7.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 193
TABLE 219 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 193
11.7.4 OFFERING FOOTPRINT OF COMPANIES (25 COMPANIES) 194
TABLE 220 OFFERING FOOTPRINT ANALYSIS OF KEY PLAYERS 194
11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 195
TABLE 221 EMPTY CAPSULES MARKET: DETAILED LIST OF KEY START-UPS/SMES 195
TABLE 222 EMPTY CAPSULES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 196
11.9 COMPETITIVE SCENARIO AND TRENDS 196
11.9.1 PRODUCT LAUNCHES 196
TABLE 223 EMPTY CAPSULES MARKET: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2023 196
11.9.2 DEALS 197
TABLE 224 EMPTY CAPSULES MARKET: DEALS, JANUARY 2020–MARCH 2023 197
11.9.3 OTHER DEVELOPMENTS 197
TABLE 225 EMPTY CAPSULES MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MARCH 2023 197
12 COMPANY PROFILES 198
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY PLAYERS 198
12.1.1 CAPSUGEL (LONZA GROUP LTD.) 198
TABLE 226 CAPSUGEL (LONZA GROUP): BUSINESS OVERVIEW 198
FIGURE 33 LONZA GROUP LTD.: COMPANY SNAPSHOT (2022) 199
12.1.2 ACG 202
TABLE 227 ACG: BUSINESS OVERVIEW 202
12.1.3 MITSUBISHI CHEMICAL HOLDINGS CORPORATION 204
TABLE 228 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION): BUSINESS OVERVIEW 204
FIGURE 34 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION): COMPANY SNAPSHOT (2021) 204
12.1.4 CAPSCANADA CORPORATION 207
TABLE 229 CAPSCANADA CORPORATION: BUSINESS OVERVIEW 207
12.1.5 NATURAL CAPSULES 209
TABLE 230 NATURAL CAPSULES: BUSINESS OVERVIEW 209
FIGURE 35 NATURAL CAPSULES: COMPANY SNAPSHOT (2021) 209
12.1.6 SUHEUNG 211
TABLE 231 SUHEUNG: BUSINESS OVERVIEW 211
12.1.7 NECTAR LIFESCIENCES LTD. 213
TABLE 232 NECTAR LIFESCIENCES LTD.: BUSINESS OVERVIEW 213
FIGURE 36 NECTAR LIFESCIENCES LTD.: COMPANY SNAPSHOT (2021) 213
12.1.8 QINGDAO YIQING MEDICINAL CAPSULE (BAOTOU DONGBAO BIOTECHNOLOGY CO., LTD.) 215
TABLE 233 QINGDAO YIQING MEDICINAL CAPSULE: BUSINESS OVERVIEW 215
12.1.9 SHANXI GUANGSHENG MEDICINAL CAPSULE 216
TABLE 234 SHANXI GUANGSHENG MEDICINAL CAPSULE: BUSINESS OVERVIEW 216
12.1.10 HEALTHCAPS INDIA 217
TABLE 235 HEALTHCAPS INDIA: BUSINESS OVERVIEW 217
12.1.11 MEDI-CAPS 219
TABLE 236 MEDI-CAPS: BUSINESS OVERVIEW 219
FIGURE 37 MEDI-CAPS: COMPANY SNAPSHOT (2021) 219
12.1.12 SNAIL PHARMA INDUSTRY 221
TABLE 237 SNAIL PHARMA INDUSTRY: BUSINESS OVERVIEW 221
12.1.13 ROXLOR 222
TABLE 238 ROXLOR: BUSINESS OVERVIEW 222
12.1.14 SUNIL HEALTHCARE 223
TABLE 239 SUNIL HEALTHCARE: BUSINESS OVERVIEW 223
FIGURE 38 SUNIL HEALTHCARE: COMPANY SNAPSHOT (2021) 224
12.1.15 BIOCAPS ENTERPRISE 226
TABLE 240 BIOCAPS ENTERPRISE: BUSINESS OVERVIEW 226
12.1.16 BRIGHT PHARMA CAPS 227
TABLE 241 BRIGHT PHARMA CAPS: BUSINESS OVERVIEW 227
12.2 OTHER COMPANIES 229
12.2.1 COMED CHEMICALS 229
TABLE 242 COMED CHEMICALS: BUSINESS OVERVIEW 229
12.2.2 SAVIOUR CAPS 230
TABLE 243 SAVIOUR CAPS: BUSINESS OVERVIEW 230
12.2.3 FORTCAPS HEALTHCARE 231
TABLE 244 FORTCAPS HEALTHCARE: BUSINESS OVERVIEW 231
12.2.4 SHAOXING ZHONGYA CAPSULE 233
TABLE 245 SHAOXING ZHONGYA CAPSULE: BUSINESS OVERVIEW 233
12.2.5 ERAWAT PHARMA LIMITED 235
TABLE 246 ERAWAT PHARMA LIMITED: BUSINESS OVERVIEW 235
12.2.6 FARMACAPSULAS 236
TABLE 247 FARMACAPSULAS: BUSINESS OVERVIEW 236
12.2.7 ZHEJIANG YUEXI CAPSULE 238
12.2.8 LFA MACHINES OXFORD 238
12.2.9 SHAOXING KANGKE CAPSULE 239
12.2.10 SHREE PHARMA CAPS 240
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 241
13.1 DISCUSSION GUIDE 241
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 245
13.3 CUSTOMIZATION OPTIONS 247
13.4 RELATED REPORTS 247
13.5 AUTHOR DETAILS 248